TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,807 | +0.6% | 253,640 | +35.0% | 0.00% | – |
| Q2 2023 | $88,302 | -31.4% | 187,878 | 0.0% | 0.00% | – |
| Q1 2023 | $128,752 | +65256.3% | 187,878 | 0.0% | 0.00% | – |
| Q4 2022 | $197 | -100.0% | 187,878 | -0.2% | 0.00% | – |
| Q3 2022 | $764,000 | -27.0% | 188,334 | +1.6% | 0.00% | – |
| Q2 2022 | $1,047,000 | -10.4% | 185,322 | 0.0% | 0.00% | – |
| Q1 2022 | $1,169,000 | -25.1% | 185,322 | +5.3% | 0.00% | – |
| Q4 2021 | $1,560,000 | +62.2% | 175,969 | +41.1% | 0.00% | – |
| Q3 2021 | $962,000 | -18.1% | 124,701 | +2.0% | 0.00% | – |
| Q2 2021 | $1,175,000 | -19.0% | 122,302 | +14.4% | 0.00% | – |
| Q1 2021 | $1,450,000 | +6.0% | 106,910 | +11.8% | 0.00% | – |
| Q4 2020 | $1,368,000 | -4.1% | 95,585 | +23.7% | 0.00% | – |
| Q3 2020 | $1,427,000 | – | 77,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |